Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Getting a diagnosis

Topic: Amyloid, tau and blood-test diagnosis

Magnetic resonance imaging based dementia severity assessment facilitates timely diagnosis of Alzheimer’s disease (AD) progression. While convolutional neural networks (CNNs) have shown effectiveness in classifying AD stages, their performance can be limited by high computational demands and class imbalance in training data. The article introduces a derivative-free optimization (DFO) approach by integrating evolutionary algorithms, Bayesian optimization, simulated annealing, neural architecture search, and pruning techniques to optimize both trainable parameters and network topology to design a lightweight CNN model (DAPA-CNN) for classifying brain MRI images into four Alzheimer-related Dementia stages (ARDS): non-Dementia (ND), mild Dementia (MD), very mild Dementia (VMD) and moderate Dementia (MoD). The proposed framework balances the dataset using Tomek links and deep SMOTE, and enhances model interpretability with class activation maps (CAMs). DAPA-CNN achieved an accuracy of 99.59% on the Alzheimer’s disease dataset (ADD), along with balanced precision (99.60%), sensitivity (99.66%), specificity (99.87%), and F1score (99.63%). across all classes. All class-wise dice and Jaccard indices and correlation metrics (Matthews correlation coefficient and Cohen’s Kappa) exceeded 0.99. Compared to a baseline CNN and contemporary architectures, DAPA-CNN reduces the number of parameters by 85.6%, processing time by 42.8%, and memory usage by 76.6%, making it suitable for resource-constrained clinical environments.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Ganesan, S. K., Velusamy, P., Parthsarathy, P., & Vasudevan, A. (2026). Alzheimer’s related dementia severity classification from magnetic resonance imaging using derivative-free optimization of convolutional neural network. Scientific Reports. https://doi.org/10.1038/s41598-026-36037-9

Vancouver

Ganesan SK, Velusamy P, Parthsarathy P, Vasudevan A. Alzheimer’s related dementia severity classification from magnetic resonance imaging using derivative-free optimization of convolutional neural network. Scientific Reports. 2026. doi:10.1038/s41598-026-36037-9. PMID: 41723164.

BibTeX

@article{ganesan2026-41723164,
  author  = {Ganesan, Saravana Kumar and Velusamy, Parthasarathy and Parthsarathy, Praveen and Vasudevan, Asokan},
  title   = {{Alzheimer’s related dementia severity classification from magnetic resonance imaging using derivative-free optimization of convolutional neural network}},
  journal = {Scientific Reports},
  year    = {2026},
  doi     = {10.1038/s41598-026-36037-9},
  pmid    = {41723164},
  url     = {https://doi.org/10.1038/s41598-026-36037-9}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study describes a computer model that classifies MRI scans into four dementia stages with high reported accuracy while using fewer parameters and less memory than other models. It is a technical classification study and does not test any treatment, cure, or prevention for Alzheimer's disease.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 41 of the 96 points it could be judged on, which is 43 of 100. Total 43 of 100.41 of the 96 points we could judge = 43 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 41 of the 96 points we could judge it on, which is 43 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.5 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 14.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Asokan Vasudevan holds only 1 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Karpagam Academy of Higher Education: institution h-index 128 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 3 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41723164)
Free to read 2 / 2 Free to read
Points 41 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 41 of the 96 points we could judge it on is 43 out of 100.
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related studies in Getting a diagnosis

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →